Sino Biopharmaceutical (SBMFF) Income Statement

Last quarter (Q2 2024), Sino Biopharmaceutical's total revenue was ¥7.94B, an increase of 3.91% from the same quarter last year. In Q2, Sino Biopharmaceutical's net income was ¥1.51B. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.